Renal Transplant Pathology Series-V

Banff category 4. Acute rejection (Acute/active T-cell-mediated rejection [TCMR])- Part II (Plasma cell-rich acute rejection)

Authors

  • Muhammed Mubarak
  • Dr. Shaheera SIUT
  • Dr. Rahma SIUT

DOI:

https://doi.org/10.53778/pjkd54189

Keywords:

NA

Author Biographies

Dr. Shaheera, SIUT

Associate Prof. Histopathology Department, SIUT, Karachi, Pakistan

Dr. Rahma, SIUT

Assistant professor, Histopathology Department, SIUT, Karachi, Pakistan

References

Charney DA, Nadasdy T, Wing-Hong-A, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 27: 791-7.

Mubarak M. Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection?. Indian J Nephrol. 2016;26(3):157-158.

Mubarak M, Abbas K, Zafar MN, Aziz T. Immunohistopathologic characterization of plasma cell-rich acute rejection in living-related renal transplant recipients. Exp Clin Transplant. 2017;15(5):516-520.

Rogers NM, Lawton PD, Jose MD. Plasma cell infiltrates and renal allograft outcomes in indigenous and non-indigenous people of the Northern Territory of Australia. Nephrology 2011; 16:777-83.

Gupta R, Sharma A, Mahanta PJ,Agarwal S K, Dinda A K. Plasma cell-rich acute rejection of the renal allograft: A distinctive morphologic form of acute rejection? Indian J Nephrol 2012; 22:184-8.

Desvaux D, Le Gouvello S, Pastural M et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma-interferon expression and poor clinical outcome. Nephrol Dial Transplant 2004; 19(4):933-9.

Gärtner V, Eigentler TK, Viebahn R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006; 81(7):986-91.

Meehan SM, Domer P, Josephson M et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001; 32(2):205-15.

Martin L, Charon-Barra C, Bocrie O et al. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction. Transpl Immunol 2010; 22(3-4):110-4.

Raghavan R, Jeroudi A, Achkar K, Gaber AO, Patel SJ, Abdellatif A. Bortezomib in kidney transplantation. J Transplant; 2010;2010:698594

Abbas K, Mubarak M, Zafar MN, Musharraf W, Imam M, Aziz T, Rizvi AH. Management of Plasma Cell-Rich Acute Rejection in Living-Related Kidney Transplant: Role of Proteasome Inhibitor. Exp Clin Transplant. 2019;17(1):42-46.

Downloads

Published

2021-12-25

How to Cite

Mubarak, M., Shakeel, S., & Rashid, R. (2021). Renal Transplant Pathology Series-V: Banff category 4. Acute rejection (Acute/active T-cell-mediated rejection [TCMR])- Part II (Plasma cell-rich acute rejection). Pakistan Journal of Kidney Diseases, 5(4), 115–119. https://doi.org/10.53778/pjkd54189